Cargando…
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration
PURPOSE: Sacubitril/valsartan is a mainstay of the treatment of heart failure with reduced ejection fraction (HFrEF); however, its effects on exercise performance yielded conflicting results. Aim of our study was to evaluate the impact of sacubitril/valsartan on exercise parameters and echocardiogra...
Autores principales: | Mapelli, Massimo, Mattavelli, Irene, Paolillo, Stefania, Salvioni, Elisabetta, Magrì, Damiano, Galotta, Arianna, De Martino, Fabiana, Mantegazza, Valentina, Vignati, Carlo, Esposito, Immacolata, Dell’Aversana, Simona, Paolillo, Roberta, Capovilla, Teresa, Tamborini, Gloria, Nepitella, Alessandro Alberto, Filardi, Pasquale Perrone, Agostoni, Piergiuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427709/ https://www.ncbi.nlm.nih.gov/pubmed/37368004 http://dx.doi.org/10.1007/s00228-023-03527-y |
Ejemplares similares
-
Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan
por: Mantegazza, Valentina, et al.
Publicado: (2021) -
Editorial: Exercise and heart failure
por: Salvioni, Elisabetta, et al.
Publicado: (2022) -
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
por: Mapelli, Massimo, et al.
Publicado: (2023) -
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
por: Mapelli, Massimo, et al.
Publicado: (2022) -
Cardiopulmonary exercise testing and heart failure: a tale born from oxygen uptake
por: Mapelli, Massimo, et al.
Publicado: (2023)